In summary, these current works elucidated that RBM15 could facilitate COAD progression and immune escape by improving ITGBL1 mRNA stability (Figure 8), providing a new avenue of therapy for COAD. This evidence concerns the gene ITGBL1 and colon adenocarcinoma.